{
    "code": "44004370",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=44004370",
    "time": "2021-04-16 09:34:32",
    "許可證字號": "衛署醫器輸壹字第004370號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "110\/05\/05",
    "發證日期": "95\/05\/05",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第一等級",
    "通關簽審文件編號": "DHA04400437007",
    "中文品名": "“艾普迪”病理診斷淋巴癌標記用一級抗體(未滅菌)",
    "英文品名": "“Epredia”  Lymphoma Markers Primary Antibody(Non-Sterile)",
    "效能": "",
    "醫器規格": "CD1a：(MS-1856)CD3：(RM-9107, RB-360, MS-401)CD4：(MS-392, MS-1528)CD5：(RM-9119, RB-9008, MS-393)CD8：(RM-9116, RB-9009, MS-457)CD10\/CALLA：(MS-728)CD15：(MS-1259)CD20：(MS-340, RB-9013)CD23：(RM-9123, RB-9071, MS-729)CD30 (Reed-Sternberg Cell Marker)：(MS-361-S0,S1,S,R7)(MS-1857)CD31\/PECAM-1：(MS-353)CD40：(RB-9238)CD43 (T-Cell Marker)：(MS-146)CD45\/LCA：(MS-355,MS-413)CD45RA：(MS-1845)CD45RB：(MS-1846)CD45RO (T-Cell Marker)：(MS-112)CD56\/NCAM-1：(MS-204)CD57 (Natural Killer Cell Marker)：(MS-136)CD74：(MS-131)CDw75：(MS-130)CD79a\/mb-1 (B-Cell Marker)：(RM-9118, MS-1171)Bcl-2alpha：(MS-123)Bcl-6：(MS-1897)Cyclin D1：(RM-9104)",
    "劑型": "",
    "包裝": "",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "醫器主類別一": "B血液學及病理學裝置",
    "醫器次類別一": "B1860免疫病理組織化學試劑與套組",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "醫器次類別三": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "",
    "限制項目": "02輸　入",
    "申請商名稱": "6231035024  普羅王企業股份有限公司",
    "申請商地址": "新北市永和區中山路一段172號10樓",
    "主製造廠": [
        {
            "製造廠名稱": "MUS5761000  RICHARD-ALLAN SCIENTIFIC LLC",
            "製造廠廠址": "4481 CAMPUS DRIVE, KALAMAZOO, MICHIGAN, 49008, USA",
            "製造廠公司地址": "",
            "製造廠國別": "UNITED STATES",
            "製程": ""
        }
    ],
    "藥理治療分類": "",
    "ingredients": []
}